BETA - What types of testing is important to monitor for BPCN over time

BETA - What types of testing is important to monitor for BPCN over time
BETA - What is intrathecal chemotherapy, and why is it used in BPDCN
BETA - What does the future of BPDCN treatment look like
Dordaviprone As A Post-transplant Maintenance for AML & MDS | Vijaya Bhatt, MBBS
Could This New BTK Degrader Change CLL Treatment? | Amit Agarwal, MD, PhD
Could This Combo Boost Response in Tough AML Cases? | Amir Fathi, MD
Older AML Treatment: New Insights From ASH! | Ira Zackon, MD
Bleximenib Breakthrough in High-Risk AML? | Hartmut Döhner, MD
TKI + Inotuzumab: Could This Be a Better Treatment? | Anand Patel, MD